Literature DB >> 9054479

Conjunctival autograft for pterygium surgery: how well does it prevent recurrence?

R S Figueiredo1, E J Cohen, J A Gomes, C J Rapuano, P R Laibson.   

Abstract

BACKGROUND AND
OBJECTIVE: The efficacy of the surgical management of pterygium with conjunctival autograft was evaluated. PATIENTS AND METHODS: In a retrospective survey, the records of 94 consecutive patients who underwent surgery for pterygium between 1984 and 1993 were reviewed. Only the first pterygium procedure for each patient performed at Wills Eye Hospital was included. The statistical technique of survival curve analysis by the Kaplan-Meier product limit was used to analyze the results separately after the removal of primary and recurrent pterygia.
RESULTS: Thirty-one patients with primary pterygium underwent simple excision. Forty patients had conjunctival autografts. The recurrence rates estimated at 1 year were 40% and 16%, respectively (P= .031). In both groups, patients who were 50 years old or younger were more likely to have a recurrence (P = .029). All 23 patients with recurrent pterygium had conjunctival grafts, and the estimation of recurrence at 1 year was 25%. No serious complications occurred in any group. *
CONCLUSION: Conjunctival autograft decreases the recurrence rate for primary pterygium compared with simple excision.

Entities:  

Mesh:

Year:  1997        PMID: 9054479

Source DB:  PubMed          Journal:  Ophthalmic Surg Lasers        ISSN: 1082-3069


  12 in total

1.  Long-term follow-up of transplantation of preserved limbal allograft and amniotic membrane for recurrent pterygium.

Authors:  Takashi Ono; Yosai Mori; Ryohei Nejima; Tadatoshi Tokunaga; Kazunori Miyata; Shiro Amano
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-08-26       Impact factor: 3.117

2.  Randomised controlled study of conjunctival autograft versus amniotic membrane graft in pterygium excision.

Authors:  P Luanratanakorn; T Ratanapakorn; O Suwan-Apichon; R S Chuck
Journal:  Br J Ophthalmol       Date:  2006-07-12       Impact factor: 4.638

3.  Amniotic membrane graft for primary pterygium: comparison with conjunctival autograft and topical mitomycin C treatment.

Authors:  D H Ma; L C See; S B Liau; R J Tsai
Journal:  Br J Ophthalmol       Date:  2000-09       Impact factor: 4.638

4.  Mitomycin C for pterygium: long term evaluation.

Authors:  F Raiskup; A Solomon; D Landau; M Ilsar; J Frucht-Pery
Journal:  Br J Ophthalmol       Date:  2004-11       Impact factor: 4.638

5.  Risk factors for pterygium recurrence after limbal-conjunctival autografting: a retrospective, single-centre investigation.

Authors:  Naser Samadi Aidenloo; Qader Motarjemizadeh; Maryam Heidarpanah
Journal:  Jpn J Ophthalmol       Date:  2018-03-16       Impact factor: 2.447

6.  Efficacy of Limbal-conjunctival Autograft Surgery with Stem Cells in Pterygium Treatment.

Authors:  Walid M Abdalla
Journal:  Middle East Afr J Ophthalmol       Date:  2009-10

7.  Recurrence of Pterygium after Pterygium Excision with Stem Cell Graft and Amniotic Membrane Graft: A Comparison.

Authors:  Syed Ahmer Hussain; Kamran Haider Shaheen; Muhammad Saad Ullah; Aamir Furqan
Journal:  Cureus       Date:  2020-01-01

8.  Mitomycin C and conjunctival autograft for recurrent pterygium.

Authors:  Uğur E Altiparmak; Yasemin Aslan Katircioğlu; Ramazan Yağci; Züleyha Yalniz; Sunay Duman
Journal:  Int Ophthalmol       Date:  2007-05-08       Impact factor: 2.029

9.  A randomized controlled prospective study to assess the role of subconjunctival bevacizumab in primary pterygium surgery in Indian patients.

Authors:  Priyanka Singh; Lopa Sarkar; H S Sethi; V S Gupta
Journal:  Indian J Ophthalmol       Date:  2015-10       Impact factor: 1.848

10.  Comparison of inferior conjunctival autografting and conjunctival tissue grafting from pterygium itself in the cases of filtering blebs and glaucoma suspects-A retrospective analysis.

Authors:  Shreesha Kumar Kodavoor; B Soundarya; Ramamurthy Dandapani
Journal:  Indian J Ophthalmol       Date:  2020-10       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.